-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $32.6M, a 64.2% increase from 2022.
- Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19.8M, a 4.68% decline from 2021.
- Rhythm Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $20.8M, a 19.2% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)